Case Study

STADA: Sustaining agility and entrepreneurship in a fast-growing pharma company

24 pages
February 2024
Reference: IMD-7-2453

Peter Goldschmidt became the CEO of pharmaceuticals company STADA in 2018. He was a firm believer in culture as a driving force – and a predictor – of organizational performance and competitiveness. A year earlier, two private equity funds had become majority owners of the “old” STADA – essentially a loose, decentralized network of country operations. After taking the helm, Goldschmidt made building a growth culture one of the strategic pillars aimed at transforming the company into a leader in consumer health, global generics and specialty pharma. As a major lever to achieve that vision, the CEO put forward four core values to define the new, aspirational brand of STADA’s culture: agility, entrepreneurship, integrity and “one STADA.” In its quest for agility, resilience and speed, STADA’s leadership recognized the need for an ambitious transformation that would improve collaboration to leverage learning, talent and technology, while centralizing some processes and reducing duplication and waste. Amid the Covid pandemic, in March 2020, STADA reported the highest production output in the group’s 125-year history. By 2022, the company was well on its way to achieving the owners’ growth objectives of becoming a strong, well-run organization. In a short span of five years, between 2018 and 2023, STADA built a platform that should allow the business to scale to five times its current size.

Learning Objective
  • Examine the tensions, choices and trade-offs that STADA’s executives had to navigate in areas such as growth, product focus, talent and local operations.
  • Appreciate the links between strategic differentiation and higher complexity: Whereas Big Pharma has significant resources to address this complexity, mid-sized firms need strategies that develop and draw on entrepreneurial, startup-like qualities to succeed.
  • Recognize the trade-offs that leaders of agile, fast-growing businesses need to make between pursuing an ambitious growth strategy and building the capabilities and breadth of talent that such a strategy demands.
  • Draw out the competing objectives and priorities that are inherent in the dual imperatives of achieving global centralization, synergy and scale vs. strengthening local, on-the-ground autonomy and empowerment.
Keywords
Organizational Behavior, Entrepreneurship, Human Resources, Leadership, Fast Growth, Culture, Core Value, Agility
Settings
World/global, Germany
Stada Arzneimittel, Healthcare, Pharmaceuticals
2017-2023
Type
Field Research
Copyright
© 2024
Available Languages
English
Related material
Teaching note
Case clearing houses
IMD case studies are distributed through case clearing houses. In order to browse the collection and purchase copies please visit the links below.

The Case Centre

Cranfield University

Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]

Harvard Business School Publishing

60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]

Asia Pacific Case Center

NUCB Business School

1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]

Contact

Research Information & Knowledge Hub for additional information on IMD publications

Discover our latest research
IMD's faculty and research teams publish articles, case studies, books and reports on a wide range of topics